Tuberculous Pericarditis in a Patient with Crohn’s Disease After Anti-tumor Necrosis Factor-Alpha Therapy

Alada, Mehmet Oğuzcan; Örmeci, Aslı Çiftcibaşı; Yılmaz, Ayşenur; Çavuş, Bilger; Yakut, Aysun; Akyüz, Filiz; Kaymakoğlu, Sabahattin

doi:10.5152/Jenterocolitis.2022.220507

Mehmet Oğuzcan Alada¹ ,

Aslı Çiftcibaşı Örmeci² ,

Ayşenur Yılmaz¹ ,

Bilger Çavuş² ,

Aysun Yakut² ,

Filiz Akyüz² ,

Sabahattin Kaymakoğlu²

¹Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul, Türkiye
²Department of Gastroenterology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye

Journal of Enterocolitis 2022; 1(1): 23-25 DOI: 10.5152/Jenterocolitis.2022.220507

Full Text PDF

Abstract

This report describes a 54-year-old female, who experiences tuberculous pericarditis after using tumor necrosis factor-alpha blocker for her diagnosis of Crohn’s disease. Following the diagnostic work-up, anti-tbc treatment was started and she had a very good response after 1 month. This case emphasizes the importance of considering the diagnosis of tuberculous pericarditis in patients who use tumor necrosis factor-alpha antagonists, even though the latent tuberculosis infection screening was negative at the beginning.

Keywords: Crohn’s disease, infliximab, pericarditis, tuberculous, tuberculosis, tumor necrosis factor inhibitors